Chargement en cours...
Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies
INTRODUCTION: Knowledge of longitudinal progression in mild Alzheimer’s disease (AD) is required for the evaluation of disease-modifying therapies. Our aim was to observe the effects of long-term cholinesterase inhibitor (ChEI) therapy in mild AD patients in a routine clinical setting. METHODS: This...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978889/ https://ncbi.nlm.nih.gov/pubmed/24099236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt210 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|